Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pre-Analytical Factors Affecting ctDNA Analysis in Early and Locally Advanced Breast Cancer

NCT05945290 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT05945290
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05945290 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pre-Analytical Factors Affecting ctDNA Analysis in Early and Locally Advanced Breast Cancer
Lead sponsor
Mayo Clinic
Phase
Observational
Overall status
Completed
Start date
July 7, 2022
Completion date
June 16, 2025
Enrollment
114 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anatomic stage i breast cancer ajcc v8, anatomic stage ii breast cancer ajcc v8, anatomic stage iii breast cancer ajcc v8, early stage breast carcinoma, locally advanced breast carcinoma